Thus, given the fact that amyloid beta (Aβ), tau and α-synuclein interact, modulate and enhance each other’s [43], an additional synergistic contribution of meth could further accelerate cognitive dysfunction during the time-course of AD, PD, and dementia with Lewy bodies (DLB). This evidence concerns the gene MAPT and Lewy body dementia.